These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 36211587
1. Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function. Sanchez-Gimenez R, Peiró ÓM, Bonet G, Carrasquer A, Fragkiadakis GA, Bulló M, Papandreou C, Bardaji A. Front Cardiovasc Med; 2022; 9():1000815. PubMed ID: 36211587 [Abstract] [Full Text] [Related]
3. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Räber L, Windecker S, Rodondi N, Nanchen D, Muller O, Miranda MX, Matter CM, Wu Y, Li L, Wang Z, Alamri HS, Gogonea V, Chung YM, Tang WH, Hazen SL, Lüscher TF. Eur Heart J; 2017 Mar 14; 38(11):814-824. PubMed ID: 28077467 [Abstract] [Full Text] [Related]
4. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD). Amrein M, Li XS, Walter J, Wang Z, Zimmermann T, Strebel I, Honegger U, Leu K, Schäfer I, Twerenbold R, Puelacher C, Glarner N, Nestelberger T, Koechlin L, Ceresa B, Haaf P, Bakula A, Zellweger M, Hazen SL, Mueller C. Clin Res Cardiol; 2022 Jun 14; 111(6):692-704. PubMed ID: 35220448 [Abstract] [Full Text] [Related]
5. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Wang Z, Tang WH, Buffa JA, Fu X, Britt EB, Koeth RA, Levison BS, Fan Y, Wu Y, Hazen SL. Eur Heart J; 2014 Apr 14; 35(14):904-10. PubMed ID: 24497336 [Abstract] [Full Text] [Related]
7. Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study. Papandreou C, Bulló M, Hernández-Alonso P, Ruiz-Canela M, Li J, Guasch-Ferré M, Toledo E, Clish C, Corella D, Estruch R, Ros E, Fitó M, Alonso-Gómez A, Fiol M, Santos-Lozano JM, Serra-Majem L, Liang L, Martínez-González MA, Hu FB, Salas-Salvadó J. Clin Chem; 2021 Jan 08; 67(1):288-297. PubMed ID: 33257943 [Abstract] [Full Text] [Related]
8. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. Mueller DM, Allenspach M, Othman A, Saely CH, Muendlein A, Vonbank A, Drexel H, von Eckardstein A. Atherosclerosis; 2015 Dec 08; 243(2):638-44. PubMed ID: 26554714 [Abstract] [Full Text] [Related]
9. Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults. Fretts AM, Hazen SL, Jensen P, Budoff M, Sitlani CM, Wang M, de Oliveira Otto MC, DiDonato JA, Lee Y, Psaty BM, Siscovick DS, Sotoodehnia N, Tang WHW, Lai H, Lemaitre RN, Mozaffarian D. JAMA Netw Open; 2022 May 02; 5(5):e2213242. PubMed ID: 35594043 [Abstract] [Full Text] [Related]
10. Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study. Lemaitre RN, Jensen PN, Wang Z, Fretts AM, McKnight B, Nemet I, Biggs ML, Sotoodehnia N, de Oliveira Otto MC, Psaty BM, Siscovick DS, Hazen SL, Mozaffarian D. JAMA Netw Open; 2021 Aug 02; 4(8):e2122844. PubMed ID: 34448864 [Abstract] [Full Text] [Related]
11. Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes. Li XS, Obeid S, Wang Z, Hazen BJ, Li L, Wu Y, Hurd AG, Gu X, Pratt A, Levison BS, Chung YM, Nissen SE, Tang WHW, Mach F, Räber L, Nanchen D, Matter CM, Lüscher TF, Hazen SL. Eur Heart J; 2019 Aug 21; 40(32):2700-2709. PubMed ID: 31049589 [Abstract] [Full Text] [Related]
12. TCA cycle metabolites associated with adverse outcomes after acute coronary syndrome: mediating effect of renal function. Sanchez-Gimenez R, Peiró ÓM, Bonet G, Carrasquer A, Fragkiadakis GA, Bulló M, Papandreou C, Bardaji A. Front Cardiovasc Med; 2023 Aug 21; 10():1157325. PubMed ID: 37441709 [Abstract] [Full Text] [Related]
13. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies. Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L. J Am Heart Assoc; 2017 Jun 29; 6(7):. PubMed ID: 28663251 [Abstract] [Full Text] [Related]
14. Plasma Concentrations of Trimethylamine-N-Oxide, Choline, and Betaine in Patients With Moderate to Advanced Chronic Kidney Disease and Their Relation to Cardiovascular and Renal Outcomes. Obeid R, Awwad H, Heine GH, Emrich IE, Fliser D, Zawada AM, Geisel J. J Ren Nutr; 2024 Nov 29; 34(6):530-538. PubMed ID: 38621431 [Abstract] [Full Text] [Related]
15. Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort. Wargny M, Croyal M, Ragot S, Gand E, Jacobi D, Trochu JN, Prieur X, Le May C, Goronflot T, Cariou B, Saulnier PJ, Hadjadj S, SURDIAGENE study group. Cardiovasc Diabetol; 2022 Jun 09; 21(1):101. PubMed ID: 35681209 [Abstract] [Full Text] [Related]
17. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes. Winther SA, Øllgaard JC, Tofte N, Tarnow L, Wang Z, Ahluwalia TS, Jorsal A, Theilade S, Parving HH, Hansen TW, Hazen SL, Pedersen O, Rossing P. Diabetes Care; 2019 Aug 09; 42(8):1512-1520. PubMed ID: 31123156 [Abstract] [Full Text] [Related]